PMID: 25773828Mar 17, 2015Paper

Prognostic role of hepatoma-derived growth factor in solid tumors of Eastern Asia: a systematic review and meta- analysis

Asian Pacific Journal of Cancer Prevention : APJCP
Ci-Hang BaoYu-Feng Cheng

Abstract

Hepatoma-derived growth factor (HDGF) is a novel jack-of-all-trades in cancer. Here we quantify the prognostic impact of this biomarker and assess how consistent is its expression in solid tumors. A comprehensive search strategy was used to search relevant literature updated on October 3, 2014 in PubMed, EMBASE and WEB of Science. Correlations between HDGF expression and clinicopathological features or cancer prognosis was analyzed. All pooled HRs or ORs were derived from random-effects models. Twenty-six studies, primarily in Eastern Asia, covering 2,803 patients were included in the analysis, all of them published during the past decade. We found that HDGF overexpression was significantly associated with overall survival (OS) (HROS=2.35, 95%CI=2.04-2.71, p<0.001) and disease free survival (DFS) (HRDFS=2.25, 95%CI =1.81-2.79, p<0.001) in solid tumors, especially in non-small cell lung cancer, hepatocellular carcinoma and cholangiocarcinoma (CCA). Moreover, multivariate survival analysis showed that HDGF overexpression was an independent predictor of poor prognosis (HROS=2.41, 95%CI: 2.02-2.81, p<0.001; HRDFS=2.39, 95%CI: 1.77-3.24, p<0.001). In addition, HDGF overexpression was significantly associated with tumor category (T3-...Continue Reading

References

Oct 6, 1997·BMJ : British Medical Journal·M EggerC Minder
May 16, 2002·Journal of Mammary Gland Biology and Neoplasia·D F HayesV Stearns
Sep 6, 2003·BMJ : British Medical Journal·Julian P T HigginsDouglas G Altman
Aug 18, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Hening RenLi Mao
Jan 7, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shinji YamamotoMorito Monden
Jan 18, 2006·Annals of Surgical Oncology·Kenya YoshidaHideji Nakamura
Oct 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hirokazu UyamaMorito Monden
May 10, 2007·International Journal of Cancer. Journal International Du Cancer·Kuo-Chin ChangTsung-Hui Hu
Mar 13, 2009·Diseases of the Colon and Rectum·Tsung-Hui HuMing-Hong Tai
Nov 1, 2011·Journal of Neuro-oncology·Shu-Shong HsuLi-Feng Liu
Jun 12, 2012·Pathology, Research and Practice·Xiaoyan ChenXiaoqiang Gan
Sep 3, 2013·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Zhifei CaoQuansheng Zhou
Nov 19, 2013·Cancer Biomarkers : Section a of Disease Markers·Shoji HanadaHideki Wanibuchi
Nov 28, 2013·Molecular and Cellular Biochemistry·Bitao ChenShitao Xia
Dec 20, 2013·Lancet·Douglas Hanahan
Jun 4, 2014·Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine·Haizhou GuoZhangsuo Liu
Jul 19, 2014·Current Opinion in Cell Biology·Paloma Ordóñez-Morán, Joerg Huelsken
Jul 30, 2014·World Journal of Gastroenterology : WJG·Feng TaoWei Wang
Sep 23, 2014·Future Oncology·Cihang BaoYufeng Cheng

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Hepatocellular carcinoma is the most common type of primary liver cancer and frequently occurs in individuals with chronic liver diseases like cirrhosis. Here is the latest research.